ZIVO — Zivo Bioscience Cashflow Statement
0.000.00%
Last trade - 00:00- $70.69m
- $69.28m
- $0.16m
Annual cashflow statement for Zivo Bioscience, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.11 | -9.16 | -8.75 | -7.78 | -13.4 |
| Non-Cash Items | 3.85 | 2.75 | 2 | 0.697 | 9.57 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.67 | -0.394 | -0.355 | 1.28 | -0.5 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -2.59 | -6.8 | -7.1 | -5.8 | -4.31 |
| Other Investing Cash Flow Items | 0 | 0 | 0 | 0 | 0 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow Items | — | -1.7 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.38 | 15.6 | 0 | 4.28 | 5.58 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.208 | 8.76 | -7.1 | -1.52 | 1.27 |